Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 477

1.

Direct conjugation of antibodies to the ZnS shell of quantum dots for FRET immunoassays with low picomolar detection limits.

Bhuckory S, Mattera L, Wegner KD, Qiu X, Wu YT, Charbonnière LJ, Reiss P, Hildebrandt N.

Chem Commun (Camb). 2016 Nov 30. [Epub ahead of print]

PMID:
27901526
2.

Erratum: Large Fermi Surface of Heavy Electrons at the Border of Mott Insulating State in NiS2.

Friedemann S, Chang H, Gamża MB, Reiss P, Chen X, Alireza P, Coniglio WA, Graf D, Tozer S, Grosche FM.

Sci Rep. 2016 Nov 10;6:36690. doi: 10.1038/srep36690. No abstract available.

3.

Prevalence and effect of pre-treatment drug resistance on the virological response to antiretroviral treatment initiated in HIV-infected children - a EuroCoord-CHAIN-EPPICC joint project.

Ngo-Giang-Huong N, Wittkop L, Judd A, Reiss P, Goetghebuer T, Duiculescu D, Noguera-Julian A, Marczynska M, Giacquinto C, Ene L, Ramos JT, Cellerai C, Klimkait T, Brichard B, Valerius N, Sabin C, Teira R, Obel N, Stephan C, de Wit S, Thorne C, Gibb D, Schwimmer C, Campbell MA, Pillay D, Lallemant M; EuroCoord-CHAIN-EPPICC joint project study group..

BMC Infect Dis. 2016 Nov 8;16(1):654.

4.

Efavirenz versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: A prospective study of HIV-positive individuals.

Cain LE, Caniglia EC, Phillips A, Olson A, Muga R, Pérez-Hoyos S, Abgrall S, Costagliola D, Rubio R, Jarrín I, Bucher H, Fehr J, van Sighem A, Reiss P, Dabis F, Vandenhende MA, Logan R, Robins J, Sterne JA, Justice A, Tate J, Touloumi G, Paparizos V, Esteve A, Casabona J, Seng R, Meyer L, Jose S, Sabin C, Hernán MA; HIV-CAUSAL Collaboration..

Medicine (Baltimore). 2016 Oct;95(41):e5133.

5.

Cigarette smoking and inflammation, monocyte activation and coagulation in HIV-infected individuals on antiretroviral therapy compared to uninfected individuals.

Kooij KW, Wit FW, Booiman T, van der Valk M, Schim van der Loeff MF, Kootstra NA, Reiss P; AGEhIV Cohort Study Group..

J Infect Dis. 2016 Sep 28. pii: jiw459. [Epub ahead of print]

PMID:
27683822
6.

Improved adipose tissue function with initiation of protease inhibitor-only ART.

Maughan RT, Feeney ER, Capel E, Capeau J, Domingo P, Giralt M, Lange JM, Phanuphak P, Cooper DA, Reiss P, Mallon PW; HIVNAT-019 Study Group..

J Antimicrob Chemother. 2016 Nov;71(11):3212-3221.

7.

Difference in Aortic Stiffness Between Treated Middle-Aged HIV Type 1-Infected and Uninfected Individuals Largely Explained by Traditional Cardiovascular Risk Factors, With an Additional Contribution of Prior Advanced Immunodeficiency.

Kooij KW, Schouten J, Wit FW, van der Valk M, Kootstra NA, Stolte IG, van der Meer JT, Prins M, Grobbee DE, van den Born BJ, Reiss P.

J Acquir Immune Defic Syndr. 2016 Sep 1;73(1):55-62. doi: 10.1097/QAI.0000000000001024.

PMID:
27513572
8.

From clinical sample to complete genome: Comparing methods for the extraction of HIV-1 RNA for high-throughput deep sequencing.

Cornelissen M, Gall A, Vink M, Zorgdrager F, Binter Š, Edwards S, Jurriaans S, Bakker M, Ong SH, Gras L, van Sighem A, Bezemer D, de Wolf F, Reiss P, Kellam P, Berkhout B, Fraser C, van der Kuyl AC; BEEHIVE Consortium..

Virus Res. 2016 Aug 4. pii: S0168-1702(16)30403-8. doi: 10.1016/j.virusres.2016.08.004. [Epub ahead of print]

PMID:
27497916
9.

Efficient eco-friendly inverted quantum dot sensitized solar cells.

Park J, Sajjad MT, Jouneau PH, Ruseckas A, Faure-Vincent J, Samuel ID, Reiss P, Aldakov D.

J Mater Chem A Mater Energy Sustain. 2016 Jan 21;4(3):827-837.

10.

The Eye as a Window to the Brain: Neuroretinal Thickness Is Associated With Microstructural White Matter Injury in HIV-Infected Children.

Blokhuis C, Demirkaya N, Cohen S, Wit FW, Scherpbier HJ, Reiss P, Abramoff MD, Caan MW, Majoie CB, Verbraak FD, Pajkrt D.

Invest Ophthalmol Vis Sci. 2016 Jul 1;57(8):3864-71. doi: 10.1167/iovs.16-19716.

PMID:
27447087
11.

Patients' Willingness to Take Multiple-Tablet Antiretroviral Therapy Regimens for Treatment of HIV.

Engelhard EA, Smit C, Vervoort SC, Smit PJ, Nieuwkerk PT, Kroon FP, Reiss P, Brinkman K, Geerlings SE.

Drugs Real World Outcomes. 2016 May 2;3(2):223-230.

12.

Synthesis of Semiconductor Nanocrystals, Focusing on Nontoxic and Earth-Abundant Materials.

Reiss P, Carrière M, Lincheneau C, Vaure L, Tamang S.

Chem Rev. 2016 Sep 28;116(18):10731-819. doi: 10.1021/acs.chemrev.6b00116.

PMID:
27391095
13.

HIV and ageing: improving quantity and quality of life.

Althoff KN, Smit M, Reiss P, Justice AC.

Curr Opin HIV AIDS. 2016 Sep;11(5):527-536.

PMID:
27367780
14.

An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype.

Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JS, Lane HC, Larder BA; RDI Data and Study Group..

J Antimicrob Chemother. 2016 Oct;71(10):2928-37. doi: 10.1093/jac/dkw217.

PMID:
27330070
15.

Compact quantum dot-antibody conjugates for FRET immunoassays with subnanomolar detection limits.

Mattera L, Bhuckory S, Wegner KD, Qiu X, Agnese F, Lincheneau C, Senden T, Djurado D, Charbonnière LJ, Hildebrandt N, Reiss P.

Nanoscale. 2016 Jun 7;8(21):11275-83. doi: 10.1039/c6nr03261c.

PMID:
27188210
16.

Large Fermi Surface of Heavy Electrons at the Border of Mott Insulating State in NiS2.

Friedemann S, Chang H, Gamża MB, Reiss P, Chen X, Alireza P, Coniglio WA, Graf D, Tozer S, Grosche FM.

Sci Rep. 2016 May 12;6:25335. doi: 10.1038/srep25335.

17.

White matter hyperintensities in relation to cognition in HIV-infected men with sustained suppressed viral load on combination antiretroviral therapy.

Su T, Wit FW, Caan MW, Schouten J, Prins M, Geurtsen GJ, Cole JH, Sharp DJ, Richard E, Reneman L, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study..

AIDS. 2016 Sep 24;30(15):2329-39. doi: 10.1097/QAD.0000000000001133.

PMID:
27149087
18.

Higher Prevalence of Hypertension in HIV-1-Infected Patients on Combination Antiretroviral Therapy Is Associated With Changes in Body Composition and Prior Stavudine Exposure.

van Zoest RA, Wit FW, Kooij KW, van der Valk M, Schouten J, Kootstra NA, Wiersinga WJ, Prins M, van den Born BJ, Reiss P; AGEhIV Cohort Study Group..

Clin Infect Dis. 2016 Jul 15;63(2):205-13. doi: 10.1093/cid/ciw285.

PMID:
27143668
19.

Longitudinal analysis of the associations between antiretroviral therapy, viraemia and immunosuppression with lipid levels: the D:A:D study.

Kamara DA, Smith C, Ryom L, Reiss P, Rickenbach M, Phillips A, Mocroft A, De Wit S, Law M, Monforte AD, Dabis F, Pradier C, Lundgren JD, Sabin C.

Antivir Ther. 2016;21(6):495-506. doi: 10.3851/IMP3051.

PMID:
27114439
20.

Liver fibrosis in HIV-infected individuals on long-term antiretroviral therapy: associated with immune activation, immunodeficiency and prior use of didanosine.

Kooij KW, Wit FW, van Zoest RA, Schouten J, Kootstra NA, van Vugt M, Prins M, Reiss P, van der Valk M; AGEhIV Cohort Study Group..

AIDS. 2016 Jul 17;30(11):1771-80. doi: 10.1097/QAD.0000000000001119.

PMID:
27088320
Items per page

Supplemental Content

Loading ...
Support Center